Wegovy Lowers Heart Attack, Stroke Risk by 20%

A new study from Novo Nordisk found the anti-obesity drug Wegovy reduced the risk of heart attack, stroke and heart-related death by 20% in people taking the drug compared to people taking a placebo.

August 10, 2023 Today's top story Wegovy Lowers Heart Attack, Stroke Risk by 20% A new study from Novo Nordisk found the anti-obesity drug Wegovy reduced the risk of heart attack, stroke and heart-related death by 20% in people taking the drug compared to people taking a placebo. Read on       Long-Term Use of Acid Reflux Drugs May Increase Your Risk of Dementia Read ON   Walking Just 4,000 Steps a Day Can Help You Live Longer Read ON   Cognitive Behavioral Therapy May Help Disordered Eating After Bariatric Surgery Read ON   More top Reads       Rise Up with Psoriasis Resources to help you celebrate, show support, and stay educated about Psoriasis. LEARN MORE       Advertisement Start a custom weight loss program Noom helps you adopt healthy habits so you can lose weight and keep it off. GET STARTED

View in browser Did a friend send you this email? Subscribe here. To see all newsletters, click here. Privacy  |  Unsubscribe Our website services, content, and products are for informational purposes only. Healthline does not provide medical advice, diagnosis, or treatment and should not be used as a substitute for medical advice from a healthcare professional. Healthline encourages you to make any treatment decisions with your healthcare professional. Healthline is owned by RVO Health. © 2023 Healthline Media LLC 275 7th Ave., 24th Floor New York, NY 10001